Sponsored content
sponsored content
Get The Weekend Point of View Newsletter
Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
FOLLOW THE HILL TIMES:
Want to make sure your whole office has the full Hill Times experience?
We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.
More Opinion
Related Stories
- Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for employers, unions, and families.
- Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for employers, unions, and families.
- On Dec. 14, the parties announced they had agreed to extend the deadline for passing legislation to create the framework for a national pharmacare program. The supply-and-confidence agreement between the two parties, established in March 2022, had called for that to be achieved by the end of 2023. The parties have now given themselves until March 1, 2024, to achieve this piece of their agreement.
- On Dec. 14, the parties announced they had agreed to extend the deadline for passing legislation to create the framework for a national pharmacare program. The supply-and-confidence agreement between the two parties, established in March 2022, had called for that to be achieved by the end of 2023. The parties have now given themselves until March 1, 2024, to achieve this piece of their agreement.
- Recent reports from the Parliamentary Budget Office found that a universal pharmacare program could cost both provincial and federal governments $11.2-billion in its first year, while the federal deficit is already projected to grow to $46.5-billion next year.
- Recent reports from the Parliamentary Budget Office found that a universal pharmacare program could cost both provincial and federal governments $11.2-billion in its first year, while the federal deficit is already projected to grow to $46.5-billion next year.
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
-
Get free news updates